Renaissance Technologies’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-88,100
Closed -$897K 3856
2020
Q3
$897K Buy
88,100
+30,500
+53% +$311K ﹤0.01% 2573
2020
Q2
$858K Sell
57,600
-21,205
-27% -$316K ﹤0.01% 2621
2020
Q1
$961K Buy
+78,805
New +$961K ﹤0.01% 2446